Peer Review History

Original SubmissionNovember 19, 2021
Decision Letter - Shazlin Shaharudin, Editor

PONE-D-21-36664Biclustering reveals potential knee OA phenotypes in exploratory analyses: Data from the Osteoarthritis InitiativePLOS ONE

Dear Dr. Nelson,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

Please submit your revised manuscript by Apr 03 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Shazlin Shaharudin

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The paper provides very good data for study related to OA. I do not think that there are concerns about dual publication, research ethics, or publication ethics. I am positive that this study will provide good data support for future research work.

Reviewer #2: This paper proposed biclustering, which is simultaneously performed on both cluster observations and clinical features, to explore candidate phenotypes of knee osteoarthritis (KOA) within the Osteoarthritis Initiative (OAI) dataset. The topic is interesting and valuable for the research community, and the manuscript can be improved by providing more details in the “Methodology” section.

In “Data preparation”, marginal distribution plots are not provided in this paper. Are these plots strongly violate the approximate normality assumption? I think this may be the motivation for using the data transformation method in [23]. More importantly, I suggest the authors justify why the knee-based approach is better than the person-based approach. In addition, what are the criteria of the data cleaning process? e.g., how to select 86 features among 116 clinical and demographic features? What kind of feature selection techniques is used?

The two essential parts of biclustering are the good measure and the suitable heuristics search method [29]. The details of the algorithm can make the manuscript more convince.

In “Strengths and Limitations”, the authors claimed that the method proposed in this paper is a novel two-step process. However, validation is a common step in any machine learning algorithm. Therefore, the authors need to update the contribution instead of overclaiming. The same problem happened in “Conclusion”, the method proposed in this paper is not new.

Minor comments:

• The “Definitions and levels” are not clear in Table 1. Are the second column definitions and third column levels? Moreover, what does “% loss of qJSW” mean?

• In S1 Figures, what is the unit of the time t (month?). In addition, these plots missed legends for different trajectories.

• Reference [16] has the format problem in page 7, section “Biclustering procedure and rationale”.

Reviewer #3: Abstract

-what has been done in the past similar studies?

-to mention the problem statement/research gap

Introduction

-mention the limitation of existing works

-is biclustering a novel approach for KOA area?

Methodology

-please detail the variables considered in the study. Those variables suddenly appear in Results sections & Figures.

e.g. 400m walk time, 20m walk pace, and force variables?

-suggest to change subheading “Outcomes” to “Analysis” instead to avoid confusion with the Results (Outcomes). Also the same word in Table 1 caption.

-subtitle “JSW loss” same as “qJSW loss”. Confusing. Please clarify.

-to detail how statistical significance is determined.

Biclustering procedure and rationale section:

-“However, the OAI database contains many variables for each knee, many of which may be uninformative for that knee’s phenotype. On one hand, such uninformative variables can hinder clustering algorithms from producing useful phenotypes, but on the other may provide crucial information for other phenotypes, and so cannot be completely discarded.”

This should be under Data Preparation/Data Cleaning stage instead.

-The writings is more towards what is biclustering, the background of biclustering and literature works instead of the authors’ actual research methodology. Please rewrite to reflect how it is applied in the case study.

Results

-please explain why only women included in the case study.

-Figures 1, 2, 5 are blur

Bicluster comparison by baseline

-Please label or indicate where is the baseline in the boxplot

e.g. “As an example, the leftmost set of boxplots shows that bicluster #1 (red) has above average values for Physical Health Summary, while 4 (cyan) and 5 (blue) have below average values.”

Where are the average values? How much?

-entire manuscript is not well written specifically the methodology & results section

-hard to relate the process mentioned in methodology to the results.

Discussion, Strength & Limitations

-These sections are well written.

Format

-mistake in citation style. Please check all.

e.g. “For example, Guan, et al utilized deep learning (DL)..

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Huanghe Zhang

Reviewer #3: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Please see attachment for formatted version of response.

RESPONSE TO REVIEWERS: PONE-D-21-36664

Reviewer #1: The paper provides very good data for study related to OA. I do not think that there are concerns about dual publication, research ethics, or publication ethics. I am positive that this study will provide good data support for future research work.

Author response: Thank you very much for your time and positive comments.

Reviewer #2: This paper proposed biclustering, which is simultaneously performed on both cluster observations and clinical features, to explore candidate phenotypes of knee osteoarthritis (KOA) within the Osteoarthritis Initiative (OAI) dataset. The topic is interesting and valuable for the research community, and the manuscript can be improved by providing more details in the “Methodology” section.

Author response: Thank you for your time and constructive comments, addressed below.

R2Q1: In “Data preparation”, marginal distribution plots are not provided in this paper. Are these plots strongly violate the approximate normality assumption? I think this may be the motivation for using the data transformation method in [23]. More importantly, I suggest the authors justify why the knee-based approach is better than the person-based approach. In addition, what are the criteria of the data cleaning process? e.g., how to select 86 features among 116 clinical and demographic features? What kind of feature selection techniques is used?

Author response/changes made: Thank you for this observation. We have added further detail regarding the approach, specifically the transformation process and variable selection criteria, under a new subheading “Preparation of the baseline dataset” on p4-5. We did not include the 172 marginal distribution plots (86 features before and after transformation) due to space and lack of additional relevant information for this analysis. See also R3Q3-4.

R2Q2: The two essential parts of biclustering are the good measure and the suitable heuristics search method [29]. The details of the algorithm can make the manuscript more convince.

Author response/changes made: In “Biclustering Procedure and Rationale”, we clarified that we used the Cheng & Church algorithm without modification, available in reference #22 (p6).

R2Q3: In “Strengths and Limitations”, the authors claimed that the method proposed in this paper is a novel two-step process. However, validation is a common step in any machine learning algorithm. Therefore, the authors need to update the contribution instead of overclaiming. The same problem happened in “Conclusion”, the method proposed in this paper is not new.

Author response/changes made: Thank you for pointing this out and allowing us to clarify one of the key strengths of this work. We have edited this sentence (p20) to read “Our work is the first application of biclustering in OA, and the first usage of SigClust for testing the significance of biclustering results in any field.” In conclusion, we changed the sentence as follows: “Novel application of existing methodologies can provide insights into OA phenotypes and development or progression of disease.”

R2Q4: The “Definitions and levels” are not clear in Table 1. Are the second column definitions and third column levels? Moreover, what does “% loss of qJSW” mean? In S1 Figures, what is the unit of the time t (month?). In addition, these plots missed legends for different trajectories.

Reference [16] has the format problem in page 7, section “Biclustering procedure and rationale”.

Author response/changes made: We have reformatted Table 1 to clarify the columns and moved the description of qJSW loss to a footnote in this table. The S1 Figures were replotted with the additional information. I am not sure what formatting issue the reviewer is referring to, but we will be happy to address anything as needed per the publisher’s requirements.

Reviewer #3:

R3Q1: Abstract, what has been done in the past similar studies? to mention the problem statement/research gap

Author response: No similar work has been done in OA. There are studies of machine learning as noted in the introduction, but there is not enough room in the abstract to expand upon this.

Changes made: Added “for the first time” to the objective statement in the abstract.

R3Q2: Introduction, mention the limitation of existing works, is biclustering a novel approach for KOA area?

Author response: See also R2Q3 and R3Q1. We added to the discussion a sentence as follows (p20) “Our work is the first application of biclustering in OA, and the first usage of SigClust for testing the significance of biclustering results in any field.”

R3Q3: Methodology, please detail the variables considered in the study. Those variables suddenly appear in Results sections & Figures (e.g., 400m walk time, 20m walk pace, and force variables). Suggest to change subheading “Outcomes” to “Analysis” instead to avoid confusion with the Results (Outcomes). Also the same word in Table 1 caption. Subtitle “JSW loss” same as “qJSW loss”. Confusing. Please clarify. To detail how statistical significance is determined.

Author response: As we note in the Methodology/Data Source and Data reporting section, All OAI data used in this paper are publicly available. Data used for these analyses are available at https://nda.nih.gov/study.html?id=911; DOI: 10.15154/1519056. Additionally, all variables are detailed in the Supplemental Table. Extensive detail about the variables is widely available in other OAI publications and on the website referenced in the paper, and as this is not the point of the present work, we did not repeat this text here.

Changes made: We changed and re-ordered the subheadings under Methodology to: Data source; Preparation of the baseline dataset; Biclustering procedure and rationale; Statistical validation of biclusters; Preparation of the follow-up dataset, and subheadings of Quantitative joint space width loss and WOMAC pain trajectories. The section on statistical validation of biclusters was moved under the section on Biclustering procedure in the methods.

R3Q4: Biclustering procedure and rationale section: “However, the OAI database contains many variables for each knee, many of which may be uninformative for that knee’s phenotype. On one hand, such uninformative variables can hinder clustering algorithms from producing useful phenotypes, but on the other may provide crucial information for other phenotypes, and so cannot be completely discarded.” This should be under Data Preparation/Data Cleaning stage instead.

Author response/changes made: We have added additional detail as recommended under the new “Preparation of the baseline dataset” section starting on page 4.

R3Q5: The writings is more towards what is biclustering, the background of biclustering and literature works instead of the authors’ actual research methodology. Please rewrite to reflect how it is applied in the case study.

Author response/changes made: Please see also R2Q2 regarding the algorithm. In the 2nd paragraph under “Biclustering procedure and rationale,” on page 6, we added the following: “In this paper, biclustering was used for phenotype identification, in the sense that knees of a given phenotype should be similar on clinical features associated with this particular phenotype, but allowed to be diverse on other variables. Thus, this two-dimensional algorithm will allow clustering of knees and clinical features simultaneously, capturing homogeneous subsets of knees with a coherent pattern across subsets of clinical features.”

R3Q6: Results: Please explain why only women included in the case study.

Author response: The OAI, and the present analysis, include men and women. There were 57% women as noted in the abstract, leaving 43% men of the 3300 individuals included in these analyses. These numbers are also provided in Table 2. We only listed the % women in the table since readers would understand the remainder are men.

R3Q7: Figures 1, 2, 5 are blur. Please label or indicate where is the baseline in the boxplot

e.g. “As an example, the leftmost set of boxplots shows that bicluster #1 (red) has above average values for Physical Health Summary, while 4 (cyan) and 5 (blue) have below average values.” Where are the average values? How much?

Author response: Thank you for calling our attention to this. We used the image preparation tool recommended by the journal and will work with them to optimize the figures before publication. Regarding the boxplot (Figure 3), we have clarified in the title that these are standardized variables and added an indication on the y-axis regarding the number of standard deviations above or below the sample average the bicluster values were. We updated the description of Figure 3 to match (page 14): As an example, the leftmost set of boxplots describes the distribution of Physical Health Summary within each bicluster. The variables have been standardized by the procedure described above (page 5), such that 0 denotes the sample mean and the box in each boxplot marks the middle 50% of the values. The interquartile range (IQR) for bicluster #1 (red) stretches from about 0 to 1, indicating that the middle 50% of knees in bicluster #1 have PHS values between 0 and 1 standard deviations above the sample mean. Biclusters #4 (cyan) and #5 (blue) have their middle 50% of knees between 0.5 and 1.5 standard deviations below the mean. Biclusters 3 and 6 do not incorporate the Physical Health Summary variable, so there is no boxplot for those biclusters.

R3Q8: entire manuscript is not well written specifically the methodology & results section; hard to relate the process mentioned in methodology to the results.

Author response: Hopefully the changes made above have addressed the reviewer’s concerns.

R3Q9: Format, mistake in citation style. Please check all. (e.g., “For example, Guan, et al utilized deep learning (DL).. )

Author response/changes made: Citations moved to immediately after et al. in this sentence and the following one, we will confirm all formatting is correct with the editorial team.

Attachments
Attachment
Submitted filename: PONED2136664_Response to reviewers032522.docx
Decision Letter - Shazlin Shaharudin, Editor

Biclustering reveals potential knee OA phenotypes in exploratory analyses: Data from the Osteoarthritis Initiative

PONE-D-21-36664R1

Dear Dr. Nelson,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Shazlin Shaharudin

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Formally Accepted
Acceptance Letter - Shazlin Shaharudin, Editor

PONE-D-21-36664R1

Biclustering reveals potential knee OA phenotypes in exploratory analyses: Data from the Osteoarthritis Initiative

Dear Dr. Nelson:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Shazlin Shaharudin

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .